This study is to collect blood and urine samples to help identify and validate protein biomarkers of recovery from moderate or severe acute kidney injury (AKI).
Study Type
OBSERVATIONAL
Enrollment
362
Unnamed facility
Washington D.C., District of Columbia, United States
Unnamed facility
Gainesville, Florida, United States
Unnamed facility
Validation of biomarkers for Acute Kidney Injury Recovery in Blood or Urine.
This study is a multi-center study intended to enroll enough subjects to validate biomarkers for acute kidney injury recovery. Subjects enrolled will be those with known moderate to severe AKI. The study is to determine the outcome of Major Adverse Kidney Event (MAKE) and Major Adverse Cardiac Event (MACE) during a period of up to 7 days.
Time frame: Day 1-7 of enrollment
None at this time
There are no secondary outcomes measures planned at this time
Time frame: 10 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chicago, Illinois, United States
Unnamed facility
Chicago, Illinois, United States
Unnamed facility
Baltimore, Massachusetts, United States
Unnamed facility
Ann Arbor, Michigan, United States
Unnamed facility
Durham, North Carolina, United States
Unnamed facility
Akron, Ohio, United States
Unnamed facility
Cleveland, Ohio, United States
Unnamed facility
Pittsburgh, Pennsylvania, United States
...and 11 more locations